Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators

Pickles Martin D.; Lowry Martin; Manton David J.; Turnbull Lindsay W.

首页> 外文期刊>European radiology >Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators

【24h】

Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators

机译：DCE-MRI对乳腺癌新辅助化疗患者的预后价值：与传统生存指标的比较

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

To determine associations between dynamic contrast-enhanced MR imaging (DCE-MRI) parameters and survival intervals in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy (NAC), surgery, and adjuvant therapies. Further, to compare the prognostic value of DCE-MRI parameters against traditional survival indicators.

机译：为了确定动态对比增强MR成像（DCE-MRI）参数与新辅助化疗（NAC），手术和辅助疗法治疗的局部晚期乳腺癌患者的生存间隔之间的关联。此外，比较DCE-MRI参数与传统生存指标的预后价值。

著录项

来源
《European radiology》 |2015年第4期|共10页
作者
Pickles Martin D.; Lowry Martin; Manton David J.; Turnbull Lindsay W.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词
Breast cancer; DCE-MRI; Magnetic resonance imaging; Prognosis; Survival;

机译：乳腺癌;DCE-MRI;磁共振成像;预后;生存;

相似文献

外文文献
中文文献
专利

1. Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators [J] . Pickles Martin D., Lowry Martin, Manton David J., European radiology . 2015,第4期

机译：DCE-MRI对乳腺癌新辅助化疗患者的预后价值：与传统生存指标的比较
2. Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy. [J] . Pickles MD, Manton DJ, Lowry M European Journal of Radiology . 2009,第3期

机译：DCE-MRI预处理参数在预测接受新辅助化疗的乳腺癌患者的无病生存期和总生存期中的预后价值。
3. Prognostic Value of Ga-68-NOTA-RGD PET/CT for Predicting Disease-Free Survival for Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy and Surgery A Comparison Study With Dynamic Contrast Enhanced MRI [J] . Kim Yong-il, Yoon Hai-Jeon, Paeng Jin Chul, Clinical nuclear medicine . 2016,第8期

机译：Ga-68-NOTA-RGD PET / CT在预测乳腺癌新辅助化疗和手术患者无病生存中的预后价值与动态对比增强MRI的比较研究
4. Prognostic Significance of COX-2 and VEGF in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy [C] . Gang-Ping WANG, Xue WANG, Zhao-Jun DING, International Conference on Biological Sciences and Technology . 2016

机译：Cox-2和VEGF在接受新辅助化疗的乳腺癌患者中的预后意义
5. Coregistration of serial breast MR studies for augmenting neoadjuvant chemotherapy response evaluation in breast cancer patients. [D] . Chittineni, Ruparani. 2008

机译：增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
6. Pre‐treatment systemic immune‐inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy [O] . Li Chen, Xiangyi Kong, Zhongzhao Wang, 2020

机译：治疗前的全身免疫炎症指数是接受新辅助化疗的乳腺癌患者的有用预后指标
7. Pre‐treatment systemic immune‐inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy [O] . Li Chen, Xiangyi Kong, Zhongzhao Wang, 2020

机译：预处理全身免疫炎症指数是乳腺癌接受新辅助化疗患者的有用预后指标

Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators

摘要

著录项

相似文献

相关主题

期刊订阅